ACADIA Pharmaceuticals Aktie
WKN: 603035 / ISIN: US0042251084
11.03.2015 21:52:04
|
BNY Mellon To Buyback Up To $3.1 Bln Stock As Fed Okays 2015 Capital Plan
(RTTNews) - BNY Mellon (BK) on Wednesday said that the Federal Reserve did not object to the company's 2015 capital plan in its Comprehensive Capital Analysis and Review.
As a result, the company's board has approved the repurchase of up to $2.4 billion of its common stock over a five-quarter period starting in the second quarter of 2015 and continuing through the second quarter of 2016.
The board also approved the repurchase of up to an additional $700 million of common stock during a portion of the period covered by the repurchase plan, contingent upon the company issuing $1 billion of preferred stock. The company's dividend remains unchanged at $0.17 per share of common stock.
"The Federal Reserve's notice not to object to our 2015 capital plan underscores the financial strength and flexibility we have to effectively deploy our capital and perform during periods of extraordinary market stress," said Gerald Hassell, chairman and chief executive officer of BNY Mellon.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu ACADIA Pharmaceuticals Inc.mehr Nachrichten
28.05.25 |
NASDAQ Composite Index-Papier ACADIA Pharmaceuticals-Aktie: So viel Verlust hätte ein Investment in ACADIA Pharmaceuticals von vor 10 Jahren bedeutet (finanzen.at) | |
21.05.25 |
Schwache Performance in New York: NASDAQ Composite zum Handelsstart in der Verlustzone (finanzen.at) | |
21.05.25 |
NASDAQ Composite Index-Papier ACADIA Pharmaceuticals-Aktie: So viel Verlust hätte eine ACADIA Pharmaceuticals-Investition von vor 5 Jahren eingebracht (finanzen.at) | |
20.05.25 |
Börse New York: NASDAQ Composite fällt am Mittag zurück (finanzen.at) | |
16.05.25 |
NASDAQ Composite-Handel aktuell: NASDAQ Composite klettert zum Handelsende (finanzen.at) | |
16.05.25 |
Börse New York: NASDAQ Composite klettert nachmittags (finanzen.at) | |
16.05.25 |
Freitagshandel in New York: NASDAQ Composite mit grünem Vorzeichen (finanzen.at) | |
16.05.25 |
Freundlicher Handel: NASDAQ Composite zum Start freundlich (finanzen.at) |
Analysen zu ACADIA Pharmaceuticals Inc.mehr Analysen
Aktien in diesem Artikel
ACADIA Pharmaceuticals Inc. | 18,74 | -4,12% |
|